Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,474 | 33,886 | 15,451 | 11,355 | 24,752 |
| Marketable Securities | 9,858 | 12,039 | 31,363 | 46,520 | 41,603 |
| Receivables | 432 | 443 | 203 | 297 | 434 |
| TOTAL | $43,481 | $48,491 | $49,655 | $60,000 | $68,509 |
| Non-Current Assets | |||||
| PPE Net | 4,854 | 5,310 | 5,584 | 5,673 | 4,652 |
| Intangibles | 57,266 | 57,299 | 57,331 | 57,364 | 57,396 |
| Other Non-Current Assets | 552 | 588 | 635 | 627 | 591 |
| TOTAL | $62,672 | $63,197 | $63,550 | $63,664 | $62,639 |
| Total Assets | $106,153 | $111,688 | $113,205 | $123,664 | $131,148 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,030 | 4,685 | 5,252 | 8,608 | 9,807 |
| Other current liabilities | 9,915 | 1 | 11,010 | N/A | 12,364 |
| TOTAL | $15,881 | $16,052 | $17,225 | $18,981 | $22,739 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 10,379 | N/A | 9,421 | N/A |
| Other Non-Current Liabilities | 2,095 | 2,278 | 2,574 | 2,870 | 2,267 |
| TOTAL | $23,612 | $24,378 | $26,965 | $32,747 | $30,856 |
| Total Liabilities | $39,493 | $40,430 | $44,190 | $51,728 | $53,595 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 174,987 | 174,987 | 170,174 | 170,146 | 169,976 |
| Common Shares | 450,282 | 448,249 | 441,299 | 440,280 | 439,148 |
| Retained earnings | -380,081 | -372,971 | -367,742 | -363,370 | -357,016 |
| Other shareholders' equity | -3,541 | -4,020 | -4,542 | -4,974 | -4,579 |
| TOTAL | $66,660 | $71,258 | $69,015 | $71,936 | $77,553 |
| Total Liabilities And Equity | $106,153 | $111,688 | $113,205 | $123,664 | $131,148 |